Researcher helps boost immune system memory against influenza

Written By :  Anshika Mishra
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-12-27 03:45 GMT   |   Update On 2023-12-27 03:45 GMT

Researchers are one step closer to making the T cell army stronger. In a recent study, researchers found that by manipulating one molecular signaling pathway in the T cells that participate in clearing influenza virus in the lungs, the strength and longevity of immunological memory produced can be improved. When humans or animals get infected, the body's immune system tries to not only clear...

Login or Register to read the full article

Researchers are one step closer to making the T cell army stronger. In a recent study, researchers found that by manipulating one molecular signaling pathway in the T cells that participate in clearing influenza virus in the lungs, the strength and longevity of immunological memory produced can be improved.

When humans or animals get infected, the body's immune system tries to not only clear the infection but also build up a memory of the pathogen that caused it. So, when the pathogen comes around again for possible reinfection, the body has an army of memory T cells that can recognize and destroy it. These T cells are a critical part of immunological memory, and an important component of efficient vaccines.

Now, researchers at the University of Missouri are one step closer to making the T cell army stronger.

This finding can potentially support the future development of more effective vaccines and therapeutics to combat influenza and other respiratory infections with the ultimate goal of increasing the body's immunological memory, which can both prevent and lessen the severity of infections and reinfections.

"This research can help us solve that problem by increasing the amount of T cells that can fight against infection. In this study, we have identified novel ways to improve the generation and long-term maintenance of protective immunity against influenza, and that is by manipulating a molecular target known as the IKK2/NFkB signaling pathway."

Reference: Curtis J. Pritzl, Dezzarae Luera, Karin M. Knudson, Michael J. Quaney, Michael J. Calcutt, Mark A. Daniels, Emma Teixeiro. IKK2/NFkB signaling controls lung resident CD8+ T cell memory during influenza infection. Nature Communications, 2023; 14 (1) DOI: 10.1038/s41467-023-40107-1

Tags:    
Article Source : Nature Communications

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News